As with many industries, Artificial intelligence (AI) enabled solutions are revolutionizing every stage of the drug development process to accelerate it and improve its efficiency. As biopharmaceutical companies increasingly rely on AI, there is a real possibility that a drug substance, drug product, or a drug formulation soon will be invented by AI. If and when that happens, who owns … Continue reading AI and Drug Development: IP Implications for Protecting AI Discoveries